Babyscripts, a leading virtual care platform for managing obstetrics, has announced the release of a first-of-its-kind product for real-time remote monitoring of maternal mental health, facilitated by a care provider. The product will be beta tested at several customer sites, including George Washington University Medical Faculty Associates (GW MFA), prior to its official launch. This is the most recent collaboration between Babyscripts…
Last week Women’s Health Innovation Coalition and Springboard in cooperation with G2G Consulting organized a congressional briefing to educate lawmakers, staff, agencies and the public on the need to advance health outcomes for women and minorities. Speakers included Avestria’s Linda Greub, Aspira Women’s Health’s Valerie Palmieri, Q2Q Health’s Roberta Powell, and Society for Women’s Health Research’s Kathryn F. Schubert. Opening remarks by Rep. Maedeleine Dean,…
2021 marks 25 years since Breast Cancer Alliance (BCA) was formed, during which time the Connecticut-based foundation has grown into a national fundraising powerhouse for breast cancer research, breast surgery fellowships and outreach and education supporting patients in underserved communities. From its inception, BCA’s mission has been to improve survival rates and quality of life for those impacted by breast cancer through…
Canadian femtech startup joni has recently launched a crowdfunding campaign on FrontFundr to attract qualified investors who want to join the company on their mission to make sustainable and innovative period care accessible. This move comes after successfully proving market-fit with their biodegradable, organic bamboo pad last year, coupled with a one-for-one giveback business model. Traditionally, early investment rounds are only accessible…
Daré, a leader in women’s health innovation has recently announced completion of patient recruitment in its Phase 1 clinical trial of DARE-HRT1 being conducted through its wholly owned subsidiary in Australia. DARE-HRT1 is a novel intravaginal ring (IVR) designed to deliver bio-identical 17β-estradiol and bio-identical progesterone continuously over a 28-day period. It is being developed for the treatment of vasomotor symptoms (VMS)…
Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that medical device executive Susan Stimson has been appointed as an independent member to the company’s Board of Directors. Ms. Stimson joins the Gynesonics’ Board with more than 25 years of experience in the development and commercialization of high-impact medical devices. She currently…
Every Thursday we send out a curated newsletter on “all things femtech and women’s health innovation”. This is the latest edition. If you’re interested in subscribing, you can do so at the bottom of this page. You’ve found some of our exclusive Inner Circle Content. This article is only available for our Inner Circle Members. To read on: Sign in to your…
About a year ago FemTech Focus launched their signature podcast and has since released 100 episodes portraying leaders from all across the women’s health innovation ecosystem. Guests have included founders, investors, researchers and many others who are united in their determination to make a difference in women’s health. To celebrate the 100th episode FemTech Focus is now organizing FemTech Summit, a 2-day…
